Search results for: 'systems conducting'

This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...

The 20th annual World Diabetes Congress of the International Diabetic Federation mentions that India leads the world in the looming epidemic of diabetes. The concept of Self-Monitoring of Blood Glucose (SMBG) was introduced in India only a few years back, and the industry has already grown to about $49.7 million with a growth rate of over 20 per...

Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

The report provides an overview of the Russian Hospital system, listing key regions and their hospitals landscapes. Key hospitals have been profiled for the regions, with details about their infrastructure, patient trends, department trends, and other relevant information. The regions selected include Moscow, St. Petersburg, Tyumen, Krasnodar, and ...

The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...

Healthcare expenditure in Malaysia is growing at a higher rate than the expenditure per capita, which translates into better healthcare provision and quality of service in the country. The Malaysian endoscopy devices market is growing under budget constraints that are forcing hospitals to focus on equipment pricing, negotiate better prices, opt fo...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

This research service presents the key findings of end users research conducted in 2007 for the Australian Wound Care Management Market. It provides insights of end-users preferred products and brands for different types of wound care. End -users' perceived product benefits and satisfaction towards products used were included. It also discussed the...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...